1348P Efficacy and safety of ceritinib 450 mg-fed vs 750 mg-fasted in Asian patients (pts) with ALK+ non-small cell lung cancer (NSCLC) in the ASCEND-8 trial

Authors :: M. Bhering
S. Lucien Geater
K. Park
Virote Sriuranpong
V. Pie Jye
S-W. Kim
L. Wang
Ullas Batra
Yirong Wang
C.-T. Yang
B.C. Chul Cho
D-W. Kim
K.G. Babu
K. Amin
Source :: Annals of Oncology. 31:S864-S865
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Ceritinib
business.industry
Internal medicine
medicine
non-small cell lung cancer (NSCLC)
Hematology
medicine.disease
business
medicine.drug

Tools